Aptadir

Aptadir Therapeutics is a preclinical biotechnology company developing novel RNA therapies. The company’s therapeutic focus is on underserved refractory cancers and genetic disorders, including difficult-to-treat diseases in the fields of oncology and rare diseases, such as myelodysplastic syndromes and Fragile X Syndrome.